Open AccessMulticenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B
Author(s) -
Ping Liu,
Yiyang Hu,
Cheng Liu,
LiangGuo Xu,
Chenghai Liu,
Kewei Sun,
Hu D,
Yong Yin,
Xingtao Zhou,
Mo-Bin Wan,
Xiong Cai,
Zhiqing Zhang,
Jun Ye,
Ren-Xing Zhou,
Jia He,
Bao-Zhang Tang
Publication year - 2005
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v11.i19.2892
Subject(s) - medicine , gastroenterology , liver function , liver function tests , fibrosis , serology , capsule , hepatitis b , hepatic fibrosis , renal function , pathology , immunology , antibody , biology , botany
To study the efficacy and safety of Fuzhenghuayu capsule (FZHY capsule, a capsule for strengthening body resistance to remove blood stasis) against liver fibrosis due to chronic hepatitis B.